Cargando…
Bisphosphonates and risk of lung cancer: Protocol for a systematic review and meta-analysis
The association between the use of bisphosphonates (BPs) and the risk of lung cancer has been concerned recently. There is no explicit study indicating that whether the use of BPs would affect the risk of lung cancer. So, we conducted a meta-analysis to figure out the relationship between BPs and lu...
Autores principales: | Li, Minghao, Zhong, Muyan, Guan, Chengnong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793382/ https://www.ncbi.nlm.nih.gov/pubmed/33429726 http://dx.doi.org/10.1097/MD.0000000000022839 |
Ejemplares similares
-
Is COVID-19 a high risk factor for lung cancer?: A protocol for systematic review and meta-analysis
por: Wu, Mingxin, et al.
Publicado: (2021) -
Impact of e-cigarettes as cancer risk: A protocol for systematic review and meta-analysis
por: de Medeiros, Kleyton Santos, et al.
Publicado: (2023) -
Association between CYP2A13 polymorphisms and lung cancer: A protocol for systematic review and meta-analysis
por: Ma, Long, et al.
Publicado: (2020) -
The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis
por: Zhang, Wei, et al.
Publicado: (2020) -
Chinese herbal medicine for small cell lung cancer patients: A protocol for a systematic review and meta-analysis
por: Mi, Xue, et al.
Publicado: (2020)